Evidence map›Paper›PMID 25332887›Full record

ArticleSpringerPlus2014

New Zealand consumers' perceptions of private insurance for pharmaceuticals.

Rajan Ragupathy, Zaheer-Ud-Din Babar, Wasif Mirza, Mitali Daiya, Himesh Chandra, Ali Yousif, Maninder Girn

Abstract read
In one paragraph

Article in SpringerPlus, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rajan RagupathyPharmacy Services, Waikato Hospital Pembroke Street, Hamilton, 3210 New Zealand.
Zaheer-Ud-Din BabarSchool of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Park Road, Auckland, 1023 New Zealand.
Wasif MirzaSchool of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Park Road, Auckland, 1023 New Zealand.
Mitali DaiyaSchool of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Park Road, Auckland, 1023 New Zealand.
Himesh ChandraSchool of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Park Road, Auckland, 1023 New Zealand.
Ali YousifSchool of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Park Road, Auckland, 1023 New Zealand.
Maninder GirnSchool of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Park Road, Auckland, 1023 New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Private insurance plays a minor role in paying for pharmaceuticals in New Zealand, despite controversy about access through the public health system. The present study examines New Zealand consumers' perceptions of private insurance for pharmaceuticals. A self-administered questionnaire was completed by 433 consumers at thirty pharmacies. The questionnaire included 18 questions on demographics, insurance status, perceptions of private insurance for pharmaceuticals and confidence in the public health system. Forty six percent of respondents had private health insurance. Respondents were more likely to have private health insurance as household income increased, and confidence in the public health system decreased. (Over two thirds of respondents were either confident or very confident in the public health system). Nineteen percent had private health insurance for pharmaceuticals, and the likelihood was not affected by household income or confidence in the public health system. Sixty one percent believed private insurance for pharmaceuticals would increase availability and affordability of pharmaceuticals. However, just over half were willing to pay for private insurance for pharmaceuticals. Of these, over two thirds were only willing to pay $20 per year or less. New Zealand pharmacy consumers' willingness to pay for private insurance for pharmaceuticals is very low.

Identifiers

PMID25332887
PMCPMC4197199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.